It has been revealed that IL-6 levels are significantly elevated in lung and breast cancer patients associated with poor prognosis; moreover, IL-6 can affect all aspects of the tumorigenesis process by regulating proliferation, apoptosis, metabolism, survival, angiogenesis, and metastasis [17]. This evidence concerns the gene IL6 and breast carcinoma.